| Literature DB >> 35631165 |
Zhenni Zhu1, Zhengyuan Wang1, Jiajie Zang1, Ye Lu1, Ziyi Xiao2, Guangyong Zheng3, Fan Wu4.
Abstract
This study aimed to explore the role of the single nucleotide polymorphism (SNP) rs516946 of the Ankyrin 1 (ANK1) gene in the relationship between dietary iron and metabolic syndrome (MetS) in the Chinese population. A total of 2766 Chinese adults (1284 males and 1482 females) were recruited. A 3-day 24-h dietary recall and weighing of household condiments were used to assess dietary intake. Anthropometric and laboratory measurements were obtained. After adjusting for age, region, years of education, intentional physical exercise, physical activity level, smoking, alcohol use and energy intake, dietary iron and the SNP rs516946 were both correlated with MetS risk and interacted among the male participants. The trend between dietary iron and MetS risk remained among T allele non-carriers of males but not among T allele carriers of males. Both the SNP rs516946 and the ferritin level correlated positively with the aspartate aminotransferase (AST) level. ANK1 SNP rs516946 interacted in the association of MetS with dietary iron among Chinese males while no association was found among females. Periodic blood loss might prevent females from these associations. The SNP rs516946 might correlate with liver function.Entities:
Keywords: dietary iron; interaction; metabolic syndrome; sex differences; single nucleotide polymorphism
Mesh:
Substances:
Year: 2022 PMID: 35631165 PMCID: PMC9147551 DOI: 10.3390/nu14102024
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Flow chart of the study participants.
Characteristics of the participants by sex.
| All | Male | Female |
| |
|---|---|---|---|---|
| 2766 (100.0) | 1284 (46.4) | 1482 (53.6) | ||
| Age (%) | 0.513 | |||
| 18–44 years | 30.8 | 30.1 | 31.4 | |
| 45–59 years | 36.2 | 36.3 | 36.1 | |
| ≥60 years | 33.0 | 33.6 | 32.6 | |
| Years of Education, years (SD 1) | 9.5 (4.5) | 10.2 (4.0) | 8.9 (4.9) | <0.001 |
| Physical Activity Level (%) | <0.001 | |||
| Sedentary | 84.2 | 78.7 | 89.0 | |
| Moderate | 13.8 | 18.1 | 10.2 | |
| Vigorous | 2.0 | 3.3 | 0.8 | |
| Intentional Physical Exercise (%) | 24.8 | 25.2 | 24.5 | 0.94 |
| Smoking Status, % | ||||
| Never smoked | 72.0 | 40.8 | 98.8 | |
| Former smoker | 5.0 | 10.5 | 0.3 | |
| Current smoker | 23.0 | 48.8 | 1.0 | |
| Alcohol use (%) | <0.001 | |||
| Lifetime abstainers | 80.7 | 64.0 | 94.9 | |
| Nonheavy drinkers | 15.1 | 27.3 | 4.6 | |
| Infrequent heavy drinkers | 1.3 | 2.6 | 0.3 | |
| Frequent heavy drinkers | 3.0 | 6.1 | 0.3 | |
| Dietary Intake | ||||
| Energy, kcal/day (SD) | 1760.9 (842.5) | 1938.5 (884.5) | 1608.9 (773.4) | <0.001 |
| Total iron, mg/day (SD) | 19.7 (16.3) | 22.0 (20.4) | 17.7 (11.3) | <0.001 |
| Heme iron, mg/day (SD) | 1.6 (1.5) | 1.7 (1.6) | 1.5 (1.4) | <0.001 |
| Nonheme iron, mg/day (SD) | 18.4 (16.6) | 20.7 (21.0) | 16.3 (10.7) | <0.001 |
| Ferritin, ng/mL (SD) | 124.5 (122.5) | 165.8 (139.2) | 87.0 (89.8) | <0.001 |
| Metabolic Syndrome (%) | 23.9 | 21.8 | 25.7 | 0.011 |
| Metabolic Syndrome Components | ||||
| Elevated blood pressure (%) | 52.4 | 56.8 | 48.7 | <0.001 |
| Elevated waist circumference (%) | 33.6 | 25.5 | 40.5 | <0.001 |
| Elevated fasting glucose (%) | 23.1 | 25.4 | 21.1 | 0.007 |
| Elevated triglycerides (%) | 27.2 | 30.3 | 24.4 | <0.001 |
| Reduced HDL-C 2, % | 21.0 | 14.8 | 26.2 | <0.001 |
| T allele presence on rs516946 (%) | 23.7 | 21.9 | 25.4 | <0.001 |
| Genotypes of rs516946 (%) | 0.079 | |||
| CC 3 | 76.3 | 78.1 | 74.7 | |
| CT 4 | 22.4 | 20.8 | 23.9 | |
| TT 5 | 1.3 | 1.1 | 1.4 |
1 SD, standard deviation; 2 HDL-C, high-density lipoprotein cholesterol; 3 CC, double C allele; 4 CT, one C allele and one T allele; 5 TT, double T allele.
Logistic regression results for MetS risk according to dietary iron and SNP rs516946 in the participants stratified by sex 1.
|
|
| |
|---|---|---|
| All | ||
| Dietary iron | 0.21 | <0.001 |
| rs516946 | 0.38 | 0.146 |
| Male | ||
| Dietary iron | 0.34 | <0.001 |
| rs516946 | 1.02 | 0.019 |
| Female | ||
| Dietary iron | 0.12 | 0.121 |
| rs516946 | 0.08 | 0.796 |
1 T allele presence of rs516946 was coded as 1 for presence and 0 for non-presence.
Multiplicative interaction results between dietary iron intake and SNP rs516946 among participants 1.
|
|
| |
|---|---|---|
| All | −0.21 | 0.033 |
| Male | −0.43 | 0.007 |
| Female | −0.11 | 0.381 |
1 T allele presence of rs516946 was coded as 1 for presence and 0 for non-presence.
Additive interaction results (95% CI) for dietary iron intake and the SNP rs516946 among the male participants 1.
| Gene Site | RERI 2 | AP 3 | S 4 |
|---|---|---|---|
| rs516946 | –0·81 (–2.23, –0.13) | –0.31 (–0.58, –0.08) | 0.70 (0.51, 0.86) |
1 T allele presence of rs516946 was coded as 1 for presence and 0 for non-presence. 2 RERI, Relative Excess Risk due to Interaction. 3 AP, Attributable Proportion; 4 S, Synergy index.
ORs (95% CI) for MetS and its components according to the quartiles of total dietary iron intake among the male participants stratified by T allele presence of rs516946 1.
| Q1 | Q2 | Q3 | Q4 | |||
|---|---|---|---|---|---|---|
| Total Iron Intake (mg/day) | <14.17 | (14.17–17.91) | (17.91–23.87) | ≥23.87 | ||
|
| 352 | 351 | 353 | 351 | ||
| Metabolic syndrome | ||||||
| Model 1 3 | T allele non-carriers | Reference | 1.36 (0.85, 2.16) | 2.06 (1.32, 3.22) | 2.14 (1.38, 3.34) | <0.001 |
| T allele carriers | 1.92 (0.99, 3.76) | 1.46 (0.63, 3.39) | 1.62 (0.76, 3.48) | 1.01 (0.41, 2.45) | 0.218 | |
| Model 2 4 | T allele non-carriers | Reference | 1.32 (0.81, 2.15) | 2.14 (1.31, 3.52) | 2.37 (1.36, 4.14) | <0.001 |
| T allele carriers | 1.78 (0.87, 3.63) | 1.48 (0.58, 3.78) | 1.97 (0.73, 5.32) | 1.81 (0.52, 6.32) | 0.854 | |
| Metabolic syndrome clinical indexes | ||||||
| Elevated blood pressure | ||||||
| Model 1 | T allele non-carriers | Reference | 1.24 (0.85, 1.83) | 1.17 (0.79, 1.72) | 1.32 (0.90, 1.95) | 0.217 |
| T allele carriers | 1.29 (0.67, 2.47) | 1.34 (0.62, 2.88) | 1.21 (0.59, 2.48) | 1.11 (0.51, 2.39) | 0.643 | |
| Model 2 | T allele non-carriers | Reference | 1.28 (0.85, 1.92) | 1.34 (0.87, 2.06) | 1.67 (1.02, 2.74) | 0.052 |
| T allele carriers | 1.12 (0.57, 2.21) | 1.33 (0.58, 3.02) | 1.23 (0.54, 2.81) | 1.37 (0.50, 3.81) | 0.757 | |
| Elevated waist circumference | ||||||
| Model 1 | T allele non-carriers | Reference | 1.52 (0.99, 2.34) | 1.86 (1.22, 2.84) | 2.07 (1.36, 3.15) | <0.001 |
| T allele carriers | 1.57 (0.82, 3.03) | 1.60 (0.72, 3.56) | 1.65 (0.79, 3.45) | 1.76 (0.80, 3.88) | 0.773 | |
| Model 2 | T allele non-carriers | Reference | 1.42 (0.91, 2.23) | 1.68 (1.07, 2.66) | 1.74 (1.04, 2.90) | 0.028 |
| T allele carriers | 1.45 (0.72, 2.92) | 1.66 (0.69, 3.97) | 2.27 (0.91, 5.63) | 3.03 (1.01, 9.14) | 0.166 | |
| Elevated fasting glucose | ||||||
| Model 1 | T allele non-carriers | Reference | 1.02 (0.67, 1.54) | 1.14 (0.76, 1.72) | 1.36 (0.91, 2.03) | 0.112 |
| T allele carriers | 0.66 (0.32, 1.35) | 1.12 (0.46, 2.70) | 1.19 (0.52, 2.69) | 1.11 (0.47, 2.66) | 0.244 | |
| Model 2 | T allele non-carriers | Reference | 1.13 (0.73, 1.75) | 1.34 (0.85, 2.13) | 1.75 (1.04, 2.93) | 0.032 |
| T allele carriers | 0.50 (0.22, 1.11) | 1.02 (0.39, 2.70) | 1.30 (0.48, 3.54) | 1.19 (0.36, 3.95) | 0.141 | |
| Elevated triglycerides | ||||||
| Model 1 | T allele non-carriers | Reference | 1.44 (0.98, 2.12) | 1.58 (1.07, 2.33) | 1.60 (1.09, 2.36) | 0.016 |
| T allele carriers | 1.48 (0.81, 2.71) | 0.94 (0.43, 2.08) | 1.41 (0.70, 2.84) | 1.21 (0.56, 2.59) | 0.890 | |
| Model 2 | T allele non-carriers | Reference | 1.42 (0.94, 2.13) | 1.53 (1.00, 2.36) | 1.63 (1.00, 2.64) | 0.049 |
| T allele carriers | 1.62 (0.85, 3.10) | 0.95 (0.40, 2.26) | 1.70 (0.72, 3.99) | 1.65 (0.57, 4.77) | 0.695 | |
| Reduced HDL-C 5 | ||||||
| Model 1 | T allele non-carriers | Reference | 0.95 (0.58, 1.56) | 1.34 (0.83, 2.14) | 1.12 (0.69, 1.82) | 0.372 |
| T allele carriers | 1.12 (0.52, 2.39) | 0.47 (0.15, 1.46) | 0.88 (0.35, 2.19) | 0.95 (0.36, 2.53) | 0.988 | |
| Model 2 | T allele non-carriers | Reference | 0.97 (0.58, 1.64) | 1.51 (0.88, 2.57) | 1.38 (0.74, 2.56) | 0.156 |
| T allele carriers | 1.16 (0.53, 2.57) | 0.59 (0.18, 1.97) | 1.25 (0.41, 3.83) | 1.81 (0.45, 7.26) | 0.441 | |
1 T allele presence on rs516946 was coded as 1 for presence and 0 for non–presence. 2 The p–value for the trend was examined using each quartile’s median of dietary iron intake. 3 Model 1 was adjusted for age. 4 Model 2 was adjusted for age, region, years of education, intentional physical exercise, physical activity level, smoking status, alcohol use and dietary total energy intake. 5 HDL-C, high-density lipoprotein cholesterol.
Figure 2The association between dietary iron intake and MetS risk stratified by the T allele presence of rs516946 among the male participants.
Pearson Correlation of AST with ferritin level and SNP rs516946 in the male participants 1.
|
| r 4 | 95% CI |
| |
|---|---|---|---|---|
| AST and ferritin level 2 | 1404 | 0.258 | (0.21, 0.31) | <0.001 |
| AST and the SNP rs516946 3 | 1400 | 0.049 | (0.00, 0.10) | 0.068 |
1 T allele presence on rs516946 was coded as 1 for presence and 0 for non–presence. 2 The correlation between AST and ferritin level was determined after adjusting for age and SNP rs516946. 3 The correlation between AST and SNP rs516946 was determined after adjusting for age and ferritin level. 4 Correlation coefficient.